Inclusion and release of fenbufen in mesoporous silica

Journal of Pharmaceutical Sciences

Volumn 99, Issue 8, 2010, Pages 3372-3380

  Carriazo, Daniel ^a,b   Del Arco, Margarita ^a   Fernández, Alicia ^a   Martín, Cristina ^a   Rives, Vicente ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE CIENCIA DE MATERIALES DE MADRID   (Spain)

Author keywords

Controlled release; FTIR; Inclusion compounds; Nanoparticles; X ray powder diffractometry

Indexed keywords

FENBUFEN; MCM 41; ARYLBUTYRIC ACID DERIVATIVE; DELAYED RELEASE FORMULATION; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; EXCIPIENT; NONSTEROID ANTIINFLAMMATORY AGENT; SILICON DIOXIDE;

AREA UNDER THE CURVE; ARTICLE; DRUG HALF LIFE; DRUG RELEASE; DRUG STRUCTURE; FOURIER TRANSFORM MASS SPECTROMETRY; IN VITRO STUDY; PH; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; DELAYED RELEASE FORMULATION; INFRARED SPECTROSCOPY; KINETICS; POROSITY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; INDICATORS AND REAGENTS; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; PHENYLBUTYRATES; POROSITY; SILICON DIOXIDE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 77955110551     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22096     Document Type: Article

References (39)

1. Khan AI, Lei L, Norquist AJ, O'Hare D. 2001. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem Commun 2342-2343. (Pubitemid 33078309)
2. Rives V, editor. 2001. Layered double hydroxides: Present and Future. NewYork: Nova Sci Pub Co Inc.
3. Ambrogi V, Fardella G, Grandolini G, Nocchetti M, Perioli L. 2003. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs. J Pharm Sci 92:1407-1418.
4. Del Arco M, Cebadera E, Gutiérrez S, Martín C, Montero MJ, Rives V, Rocha J, Sevilla MA. 2004. Mg, Al layered double hydroxides with intercalated indomethacin: Synthesis, characterization and pharmacological study. J Pharm Sci 92:1649-1658.
5. Dupin JC, Martinez H, Guimon C, Dumitriu E, Fechete I. 2004. Intercalation compounds of Mg-Al layered double hydroxides with dichlophenac: Different methods of preparation and physico-chemical characterization. Appl Clay Sci 27:95-106.
6. Trikeriotis M, Ghanotakis DF. 2007. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. Int J Pharm 332:176-184. (Pubitemid 46237703)
7. Hou WG, Jin ZL. 2007. Synthesis and characterization of Naproxen intercalated Zn-Al layered double hydroxides. Colloid Polym Sci 285:1449-1454.
8. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC. (Mobil Oil Corp.). 1992. US Patent, 5098684.
9. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. 1992. Ordered mesoporous moleculas sieves synthesized by a liquid-crystal template mechanism. Nature 359:710-712.
10. Myers D. 1992. Surfartant science and technology. New York: Wiley-VCH.
11. Steel A, Carr SW, Anderson MW. 1994. 14N NMR study of surfactant mesophases in the synthesis of mesoporous silicates. J Chem Soc Chem Commun 1571-1572.
12. Corma A. 1997. From microporous to mesoporous molecular sieve materials and their use in catalysis. Chem Rev 97:2373-2420.
13. Brunel D. 1999. Functionalised micelle-templated silicas (MTS) and their use as catalysts for fine chemicals. Micro Meso Mater 27:329-344.
14. Cai Q, Luo ZS, Pang WQ, Fan YW, Chen XH, Cui FZ. 2001. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium. Chem Mater 13:258-263.
15. Vallet-Reǵ M, Rámila A, Del Real PP, Pérez-Pariente J. 2001. A new property of MCM-41: Drugs delivery systems. Chem Mater 13:308-311.
16. Lawrence MJ. 1994. Surfactant systems: Their use in drug delivery. Chem Soc Rev 23:417-424. (Pubitemid 24986161)
17. Muñoz B, Ramila A, Pérez-Pariente J, Diaz I, Vallet-Regí M. 2003. MCM-41 Organic modification as drug delivery rate regulator. Chem Mater 15:500-503.
18. Horcajada P, Rámila A, Pérez-Pariente J, Vallet-Regí M. 2004. Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor Mesopor Mater 68:105-109.
19. Charnay C, Begú S, Tourné-Péteilh C, Nicole L, Lerner DA, Devoisselle JM. 2004. Inclusion of ibuprofen in mesoporous templated silica: Drug loading and release property. Eur J Pharm Biopharm 57:533-540.
20. Izquierdo-Barba I, Martínez A, Doadrio AL, Pérez-Pariente J, Vallet-Regí M. 2005. Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 26:365-373.
21. Zhu YF, Shi Jl, Li YS, Chen HR, Shen WH, Don XP. 2005. Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Micropor Mesopor Mat 85:75-81.
22. Qu F, Zhu G, Lin H, Sun J, Zhang D, Li Sh, Qiu Sh. 2006. Drugs self-template synthesis of ibuprofen/mesoporous silica for sustained release. Eur J Inorg Chem 3943-3947.
23. Vallet-Regí M, Balas F, Arcos D. 2007. Mesoporous materials for drug delivery. Angew Chem Int Ed 46:2-13.
24. Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123-133.
25. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35. (Pubitemid 13092121)
26. Peppas NA. 1985. Análisis of fickian and nonfickian drug release from polymers. Pharm Acta Helv 60:110-111.
27. Boraie NA, El-Khawas M, Naggar VF. 1990. A study of prolongued release kinetics of soluble drugs from various hydrophylic directrly compressed cellulosic matrices. Sci Tech Pract Pharm 16:6-14.
28. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, Chu CTW, Olson DH, Sheppared EW, McCullen SB, Higgins JB, Schlenker JL. 1992. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc 114:10834-10843.
29. Ciesla U, Schüth F. 1999. Ordered mesoporous materials. Micropor Mesopor Mater 27:131-149.
30. Taner TP, Pinnavaia TJ. 1995. A neutral templating route to mesoporous. Mol Sieves Sci 267:865-867.
31. Chen CY, Burkett SL, Li HX, Davis ME. 1993. Studies on mesoporous materials II. Synthesis and characterization of MCM-41. Micropor Mater 2:27-34.
32. Marler B, Oberhagemann U, Vortmann S, Gies H. 1996. Influence of the sorbate type on XRD peak intensities of loaded MCM-41. Micropor Mater 6:375-383.
33. Ambrogi V, Perioli L, Marmottini F, Accorsi O, Pagano C, Ricci M, Rossi C. 2008. Role of mesoporous silicates on carbamazepine dissolution rate enhancement. Micropor Mesopor Mater 113:445-452.
34. Sliwinska-Bartkowiak M, Dudziak G, Gras R, Sikorski R, Gubbins KE. 2001. Freezing behaviour in porous glasses and MCM-41. Colloid Surf A 187, 188:523-529.
35. Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti R, Rouquerol J, Sieminiewska T. 1985. Reporting physisorption data for gas solid systems with special reference to the determination of surface-area and porosity. Pure Appl Chem 57:603-619.
36. Onida B, Bonelli B, Flora L, Teobaldo F, Otero Areán C, Garrone E. 2001. Permeability of micelles in surfactant-containing MCM-41 silica as monitored by embedded dye molecules. Chem Commun 2216-2217. (Pubitemid 33052110)
37. Manzano M, Aina V, Areán CO, Balas F, Cauda V, Colilla M, Delgado MR, Vallet-Regí M. 2008. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem Eng J 137:30-37.
38. -). J Chem Soc Chem Commun 756-757.
39. Vallet-Regí M. 2006. Ordered mesoporous materials in the context of drugs delivery systems and bone tissue engineering. Chem Eur J 12:5934-5943.